Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune‐mediated thrombotic thrombocytopenic purpura in the United States
Publisher: Research and practice in thrombosis and haemostasis (rpth)Authors: A. Adeyemi, F. Razakariasa, A. Chiorean, R. de Passos Sousa View publication Background Immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is a life‐threatening thrombotic microangiopathy. Due to its rarity, epidemiology and real‐world outcomes data are scarce. Objectives The aim was to assess epidemiology, treatment patterns, clinical outcomes, and […]
